21: Psychedelic Venture Capital - Interview with Ken Belotsky and Stuart Seidman of Negev Capital Brom Podcast

Negev Capital is a VC fund focused on psychedelic medicine.  

In this episode of The Integration Conversation, Ken Belotsky and Stuart Seidman tell us about Negev's founding, its strategy, and what it's like to run a venture fund in the psychedelics space.    



❤️ Help us fund the future of psychedelic medicine at Empath Ventures: https://www.empath.vc 

⭐️ Become an Integration Insider and get early access to episodes: https://patreon.com/theintegrationco 

🐦 brom on twitter:  

https://twitter.com/therealbrom 

🎇 Clips and other stuff on Instagram:  

https://instagram.com/theintegrationco 

⏰ Timestamps:  

0:45 - Ken & Stuart’s backgrounds  

6:00 - what is it like raising money for a Psychedelic Venture Fund?  

14:00 - what is Negev’s focus?   

19:30 - how do you do due diligence?   

23:30 - do novel psychedelics replace the classic psychedelics in the long run?   

26:30 - what are the developing trends in psychedelics?   

37:30 - is there too much capital in the space?